APO Research
Talk to an analyst

APO RESEARCH · REPORT

Large Volume Parenteral (LVP)

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.

Selected research

Market Structure

Global Large Volume Parenteral (LVP) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025194 pages

Choose your research edition.

Industry ResearchLarge Volume Parenteral (LVP) Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Large Volume Parenteral (LVP) Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Large Volume Parenteral (LVP) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Large Volume Parenteral (LVP) Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Large Volume Parenteral (LVP) Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.

The main Large Volume Parenteral (LVP) players include Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, etc. The top five Large Volume Parenteral (LVP) players account for approximately 66% of the total global market. Asia-Pacific is the largest consumer market for Large Volume Parenteral (LVP) accounting for about 47%, followed by Europe and North America. In terms of Type, Soft Bag LVP is the largest segment, with a share about 56%. And in terms of Application, the largest application is Therapeutic Infusion, followed by Basic Infusion.

This report provides an overview of the global Large Volume Parenteral (LVP) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Large Volume Parenteral (LVP) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Large Volume Parenteral (LVP) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Large Volume Parenteral (LVP) market size, projected growth trends, production technologies, key applications, and end-use industries.

Large Volume Parenteral (LVP) Segment by Company

Baxter Healthcare

Kelun Pharma

B. Braun

Fresenius

Teva Pharmaceutical Industries

Pfizer (Hospira)

Ostuka Pharmaceutical

CR Double-Crane

Pisa

Huaren

Patheon

Beximco Pharma

Albert David

PSI Ltd

Ozon Pharmaceuticals

BAG Healthcare

BML Parenteral Drugs

Large Volume Parenteral (LVP) Segment by Type

Soft Bag LVP

Plastic Bottle LVP

Glass Bottle LVP

Large Volume Parenteral (LVP) Segment by Application

Basic Infusion

Therapeutic Infusion

Nutritious Infusion

Large Volume Parenteral (LVP) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Large Volume Parenteral (LVP) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Large Volume Parenteral (LVP) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Large Volume Parenteral (LVP).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Large Volume Parenteral (LVP) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Large Volume Parenteral (LVP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Large Volume Parenteral (LVP) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Large Volume Parenteral (LVP) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Large Volume Parenteral (LVP) Industry Trends Table 2. Large Volume Parenteral (LVP) Industry Drivers Table 3. Large Volume Parenteral (LVP) Industry Opportunities and Challenges Table 4. Large Volume Parenteral (LVP) Industry Restraints Table 5. Global Large Volume Parenteral (LVP) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Large Volume Parenteral (LVP) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Large Volume Parenteral (LVP) Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers Table 9. Global Large Volume Parenteral (LVP) Average Sales Price (US$/K Units) of Manufacturers (2021-2026) Table 10. Global Large Volume Parenteral (LVP) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Large Volume Parenteral (LVP) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Large Volume Parenteral (LVP) Manufacturers, Product Type & Application Table 13. Global Large Volume Parenteral (LVP) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Large Volume Parenteral (LVP) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Soft Bag LVP Table 17. Major Manufacturers of Plastic Bottle LVP Table 18. Major Manufacturers of Glass Bottle LVP Table 19. Global Large Volume Parenteral (LVP) Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 20. Global Large Volume Parenteral (LVP) Sales by Type (2021-2026) & (M Units) Table 21. Global Large Volume Parenteral (LVP) Sales by Type (2027-2032) & (M Units) Table 22. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2021-2026) Table 23. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2027-2032) Table 24. Global Large Volume Parenteral (LVP) Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 25. Global Large Volume Parenteral (LVP) Revenue by Type (2021-2026) & (M Units) Table 26. Global Large Volume Parenteral (LVP) Revenue by Type (2027-2032) & (M Units) Table 27. Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2021-2026) Table 28. Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Basic Infusion Table 30. Major Manufacturers of Therapeutic Infusion Table 31. Major Manufacturers of Nutritious Infusion Table 32. Global Large Volume Parenteral (LVP) Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 33. Global Large Volume Parenteral (LVP) Sales by Application (2021-2026) & (M Units) Table 34. Global Large Volume Parenteral (LVP) Sales by Application (2027-2032) & (M Units) Table 35. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2021-2026) Table 36. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2027-2032) Table 37. Global Large Volume Parenteral (LVP) Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 38. Global Large Volume Parenteral (LVP) Revenue by Application (2021-2026) & (M Units) Table 39. Global Large Volume Parenteral (LVP) Revenue by Application (2027-2032) & (M Units) Table 40. Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2021-2026) Table 41. Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2027-2032) Table 42. Global Large Volume Parenteral (LVP) Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 43. Global Large Volume Parenteral (LVP) Sales by Region (2021-2026) & (M Units) Table 44. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2021-2026) Table 45. Global Large Volume Parenteral (LVP) Sales Forecasted by Region (2027-2032) & (M Units) Table 46. Global Large Volume Parenteral (LVP) Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Large Volume Parenteral (LVP) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 48. North America Large Volume Parenteral (LVP) Sales by Country (2021-2026) & (M Units) Table 49. North America Large Volume Parenteral (LVP) Sales by Country (2027-2032) & (M Units) Table 50. Europe Large Volume Parenteral (LVP) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 51. Europe Large Volume Parenteral (LVP) Sales by Country (2021-2026) & (M Units) Table 52. Europe Large Volume Parenteral (LVP) Sales by Country (2027-2032) & (M Units) Table 53. Asia Pacific Large Volume Parenteral (LVP) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 54. Asia Pacific Large Volume Parenteral (LVP) Sales by Country (2021-2026) & (M Units) Table 55. Asia Pacific Large Volume Parenteral (LVP) Sales by Country (2027-2032) & (M Units) Table 56. South America, Middle East and Africa Large Volume Parenteral (LVP) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 57. South America, Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2021-2026) & (M Units) Table 58. South America, Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2027-2032) & (M Units) Table 59. Global Large Volume Parenteral (LVP) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Large Volume Parenteral (LVP) Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Large Volume Parenteral (LVP) Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2021-2026) Table 63. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2027-2032) Table 64. Baxter Healthcare Company Information Table 65. Baxter Healthcare Business Overview Table 66. Baxter Healthcare Large Volume Parenteral (LVP) Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio Table 68. Baxter Healthcare Recent Development Table 69. Kelun Pharma Company Information Table 70. Kelun Pharma Business Overview Table 71. Kelun Pharma Large Volume Parenteral (LVP) Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Kelun Pharma Large Volume Parenteral (LVP) Product Portfolio Table 73. Kelun Pharma Recent Development Table 74. B. Braun Company Information Table 75. B. Braun Business Overview Table 76. B. Braun Large Volume Parenteral (LVP) Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. B. Braun Large Volume Parenteral (LVP) Product Portfolio Table 78. B. Braun Recent Development Table 79. Fresenius Company Information Table 80. Fresenius Business Overview Table 81. Fresenius Large Volume Parenteral (LVP) Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Fresenius Large Volume Parenteral (LVP) Product Portfolio Table 83. Fresenius Recent Development Table 84. Teva Pharmaceutical Industries Company Information Table 85. Teva Pharmaceutical Industries Business Overview Table 86. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Portfolio Table 88. Teva Pharmaceutical Industries Recent Development Table 89. Pfizer (Hospira) Company Information Table 90. Pfizer (Hospira) Business Overview Table 91. Pfizer (Hospira) Large Volume Parenteral (LVP) Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Pfizer (Hospira) Large Volume Parenteral (LVP) Product Portfolio Table 93. Pfizer (Hospira) Recent Development Table 94. Ostuka Pharmaceutical Company Information Table 95. Ostuka Pharmaceutical Business Overview Table 96. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio Table 98. Ostuka Pharmaceutical Recent Development Table 99. CR Double-Crane Company Information Table 100. CR Double-Crane Business Overview Table 101. CR Double-Crane Large Volume Parenteral (LVP) Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. CR Double-Crane Large Volume Parenteral (LVP) Product Portfolio Table 103. CR Double-Crane Recent Development Table 104. Pisa Company Information Table 105. Pisa Business Overview Table 106. Pisa Large Volume Parenteral (LVP) Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Pisa Large Volume Parenteral (LVP) Product Portfolio Table 108. Pisa Recent Development Table 109. Huaren Company Information Table 110. Huaren Business Overview Table 111. Huaren Large Volume Parenteral (LVP) Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Huaren Large Volume Parenteral (LVP) Product Portfolio Table 113. Huaren Recent Development Table 114. Patheon Company Information Table 115. Patheon Business Overview Table 116. Patheon Large Volume Parenteral (LVP) Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Patheon Large Volume Parenteral (LVP) Product Portfolio Table 118. Patheon Recent Development Table 119. Beximco Pharma Company Information Table 120. Beximco Pharma Business Overview Table 121. Beximco Pharma Large Volume Parenteral (LVP) Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio Table 123. Beximco Pharma Recent Development Table 124. Albert David Company Information Table 125. Albert David Business Overview Table 126. Albert David Large Volume Parenteral (LVP) Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Albert David Large Volume Parenteral (LVP) Product Portfolio Table 128. Albert David Recent Development Table 129. PSI Ltd Company Information Table 130. PSI Ltd Business Overview Table 131. PSI Ltd Large Volume Parenteral (LVP) Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. PSI Ltd Large Volume Parenteral (LVP) Product Portfolio Table 133. PSI Ltd Recent Development Table 134. Ozon Pharmaceuticals Company Information Table 135. Ozon Pharmaceuticals Business Overview Table 136. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio Table 138. Ozon Pharmaceuticals Recent Development Table 139. BAG Healthcare Company Information Table 140. BAG Healthcare Business Overview Table 141. BAG Healthcare Large Volume Parenteral (LVP) Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. BAG Healthcare Large Volume Parenteral (LVP) Product Portfolio Table 143. BAG Healthcare Recent Development Table 144. BML Parenteral Drugs Company Information Table 145. BML Parenteral Drugs Business Overview Table 146. BML Parenteral Drugs Large Volume Parenteral (LVP) Sales (M Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio Table 148. BML Parenteral Drugs Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Large Volume Parenteral (LVP) Distributors List Table 152. Large Volume Parenteral (LVP) Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Large Volume Parenteral (LVP) Product Image Figure 2. Global Large Volume Parenteral (LVP) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Large Volume Parenteral (LVP) Market Size (2021-2032) & (US$ Million) Figure 4. Global Large Volume Parenteral (LVP) Sales (2021-2032) & (M Units) Figure 5. Global Large Volume Parenteral (LVP) Average Price (US$/K Units) & (2021-2032) Figure 6. Global Top 5 and 10 Large Volume Parenteral (LVP) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Soft Bag LVP Image Figure 9. Plastic Bottle LVP Image Figure 10. Glass Bottle LVP Image Figure 11. Global Large Volume Parenteral (LVP) Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 12. Global Large Volume Parenteral (LVP) Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2021-2032) Figure 14. Global Large Volume Parenteral (LVP) Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 15. Global Large Volume Parenteral (LVP) Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2021-2032) Figure 17. Basic Infusion Image Figure 18. Therapeutic Infusion Image Figure 19. Nutritious Infusion Image Figure 20. Global Large Volume Parenteral (LVP) Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 21. Global Large Volume Parenteral (LVP) Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2021-2032) Figure 23. Global Large Volume Parenteral (LVP) Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 24. Global Large Volume Parenteral (LVP) Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2021-2032) Figure 26. North America Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 27. North America Large Volume Parenteral (LVP) Sales Market Share by Country (2021-2032) Figure 28. U.S. Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 29. Canada Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 30. Mexico Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 31. Europe Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 32. Europe Large Volume Parenteral (LVP) Sales Market Share by Country (2021-2032) Figure 33. Germany Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 34. France Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 35. U.K. Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 36. Italy Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Netherlands Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 38. Asia Pacific Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 39. Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Country (2021-2032) Figure 40. China Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 41. Japan Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 42. South Korea Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 43. Southeast Asia Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 44. India Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 45. Australia Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 46. South America, Middle East and Africa Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 47. South America, Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Country (2021-2032) Figure 48. Brazil Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 49. South Africa Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 50. Saudi Arabia Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 51. Turkey Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 52. Argentina Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 53. UAE Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 54. Egypt Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 55. Chile Large Volume Parenteral (LVP) Sales and Growth Rate (2021-2032) & (M Units) Figure 56. Global Large Volume Parenteral (LVP) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Large Volume Parenteral (LVP) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Figure 59. North America Large Volume Parenteral (LVP) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Figure 61. Europe Large Volume Parenteral (LVP) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Large Volume Parenteral (LVP) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Large Volume Parenteral (LVP) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Large Volume Parenteral (LVP) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Large Volume Parenteral (LVP) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Soft Bag LVP
  • Plastic Bottle LVP
  • Glass Bottle LVP
Applications
  • Basic Infusion
  • Therapeutic Infusion
  • Nutritious Infusion
Companies covered
  • Baxter Healthcare
  • Kelun Pharma
  • B. Braun
  • Fresenius
  • Teva Pharmaceutical Industries
  • Pfizer (Hospira)
  • Ostuka Pharmaceutical
  • CR Double-Crane
  • Pisa
  • Huaren
  • Patheon
  • Beximco Pharma
  • Albert David
  • PSI Ltd
  • Ozon Pharmaceuticals
  • BAG Healthcare
  • BML Parenteral Drugs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Large Volume Parenteral (LVP) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Large Volume Parenteral (LVP) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Large Volume Parenteral (LVP) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Large Volume Parenteral (LVP) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Large Volume Parenteral (LVP) Market Dynamics
  1. 2.1 Large Volume Parenteral (LVP) Industry Trends
  2. 2.2 Large Volume Parenteral (LVP) Industry Drivers
  3. 2.3 Large Volume Parenteral (LVP) Industry Opportunities and Challenges
  4. 2.4 Large Volume Parenteral (LVP) Industry Restraints
3 Large Volume Parenteral (LVP) Market by Manufacturers
  1. 3.1 Global Large Volume Parenteral (LVP) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Large Volume Parenteral (LVP) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Large Volume Parenteral (LVP) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Large Volume Parenteral (LVP) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Large Volume Parenteral (LVP) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Large Volume Parenteral (LVP) Manufacturers, Product Type & Application
  7. 3.7 Global Large Volume Parenteral (LVP) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Large Volume Parenteral (LVP) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Large Volume Parenteral (LVP) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Large Volume Parenteral (LVP) Tier 1, Tier 2, and Tier 3
4 Large Volume Parenteral (LVP) Market by Type
  1. 4.1 Large Volume Parenteral (LVP) Type Introduction
  2. 4.1.1 Soft Bag LVP
  3. 4.1.2 Plastic Bottle LVP
  4. 4.1.3 Glass Bottle LVP
  5. 4.2 Global Large Volume Parenteral (LVP) Sales by Type
  6. 4.2.1 Global Large Volume Parenteral (LVP) Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Large Volume Parenteral (LVP) Sales by Type (2021-2032)
  8. 4.2.3 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2021-2032)
  9. 4.3 Global Large Volume Parenteral (LVP) Revenue by Type
  10. 4.3.1 Global Large Volume Parenteral (LVP) Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Large Volume Parenteral (LVP) Revenue by Type (2021-2032)
  12. 4.3.3 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2021-2032)
5 Large Volume Parenteral (LVP) Market by Application
  1. 5.1 Large Volume Parenteral (LVP) Application Introduction
  2. 5.1.1 Basic Infusion
  3. 5.1.2 Therapeutic Infusion
  4. 5.1.3 Nutritious Infusion
  5. 5.2 Global Large Volume Parenteral (LVP) Sales by Application
  6. 5.2.1 Global Large Volume Parenteral (LVP) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Large Volume Parenteral (LVP) Sales by Application (2021-2032)
  8. 5.2.3 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Large Volume Parenteral (LVP) Revenue by Application
  10. 5.3.1 Global Large Volume Parenteral (LVP) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Large Volume Parenteral (LVP) Revenue by Application (2021-2032)
  12. 5.3.3 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2021-2032)
6 Global Large Volume Parenteral (LVP) Sales by Region
  1. 6.1 Global Large Volume Parenteral (LVP) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Large Volume Parenteral (LVP) Sales by Region (2021-2032)
  3. 6.2.1 Global Large Volume Parenteral (LVP) Sales by Region (2021-2026)
  4. 6.2.2 Global Large Volume Parenteral (LVP) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Large Volume Parenteral (LVP) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Large Volume Parenteral (LVP) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Large Volume Parenteral (LVP) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Large Volume Parenteral (LVP) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Large Volume Parenteral (LVP) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Large Volume Parenteral (LVP) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Large Volume Parenteral (LVP) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Large Volume Parenteral (LVP) Revenue by Region
  1. 7.1 Global Large Volume Parenteral (LVP) Revenue by Region
  2. 7.1.1 Global Large Volume Parenteral (LVP) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Large Volume Parenteral (LVP) Revenue by Region (2021-2026)
  4. 7.1.3 Global Large Volume Parenteral (LVP) Revenue by Region (2027-2032)
  5. 7.1.4 Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Large Volume Parenteral (LVP) Revenue (2021-2032)
  8. 7.2.2 North America Large Volume Parenteral (LVP) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Large Volume Parenteral (LVP) Revenue (2021-2032)
  11. 7.3.2 Europe Large Volume Parenteral (LVP) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Large Volume Parenteral (LVP) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Large Volume Parenteral (LVP) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Large Volume Parenteral (LVP) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Large Volume Parenteral (LVP) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Baxter Healthcare
  2. 8.1.1 Baxter Healthcare Company Information
  3. 8.1.2 Baxter Healthcare Business Overview
  4. 8.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio
  6. 8.1.5 Baxter Healthcare Recent Developments
  7. 8.2 Kelun Pharma
  8. 8.2.1 Kelun Pharma Company Information
  9. 8.2.2 Kelun Pharma Business Overview
  10. 8.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Kelun Pharma Large Volume Parenteral (LVP) Product Portfolio
  12. 8.2.5 Kelun Pharma Recent Developments
  13. 8.3 B. Braun
  14. 8.3.1 B. Braun Company Information
  15. 8.3.2 B. Braun Business Overview
  16. 8.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 B. Braun Large Volume Parenteral (LVP) Product Portfolio
  18. 8.3.5 B. Braun Recent Developments
  19. 8.4 Fresenius
  20. 8.4.1 Fresenius Company Information
  21. 8.4.2 Fresenius Business Overview
  22. 8.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fresenius Large Volume Parenteral (LVP) Product Portfolio
  24. 8.4.5 Fresenius Recent Developments
  25. 8.5 Teva Pharmaceutical Industries
  26. 8.5.1 Teva Pharmaceutical Industries Company Information
  27. 8.5.2 Teva Pharmaceutical Industries Business Overview
  28. 8.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Portfolio
  30. 8.5.5 Teva Pharmaceutical Industries Recent Developments
  31. 8.6 Pfizer (Hospira)
  32. 8.6.1 Pfizer (Hospira) Company Information
  33. 8.6.2 Pfizer (Hospira) Business Overview
  34. 8.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Product Portfolio
  36. 8.6.5 Pfizer (Hospira) Recent Developments
  37. 8.7 Ostuka Pharmaceutical
  38. 8.7.1 Ostuka Pharmaceutical Company Information
  39. 8.7.2 Ostuka Pharmaceutical Business Overview
  40. 8.7.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
  42. 8.7.5 Ostuka Pharmaceutical Recent Developments
  43. 8.8 CR Double-Crane
  44. 8.8.1 CR Double-Crane Company Information
  45. 8.8.2 CR Double-Crane Business Overview
  46. 8.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CR Double-Crane Large Volume Parenteral (LVP) Product Portfolio
  48. 8.8.5 CR Double-Crane Recent Developments
  49. 8.9 Pisa
  50. 8.9.1 Pisa Company Information
  51. 8.9.2 Pisa Business Overview
  52. 8.9.3 Pisa Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pisa Large Volume Parenteral (LVP) Product Portfolio
  54. 8.9.5 Pisa Recent Developments
  55. 8.10 Huaren
  56. 8.10.1 Huaren Company Information
  57. 8.10.2 Huaren Business Overview
  58. 8.10.3 Huaren Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Huaren Large Volume Parenteral (LVP) Product Portfolio
  60. 8.10.5 Huaren Recent Developments
  61. 8.11 Patheon
  62. 8.11.1 Patheon Company Information
  63. 8.11.2 Patheon Business Overview
  64. 8.11.3 Patheon Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Patheon Large Volume Parenteral (LVP) Product Portfolio
  66. 8.11.5 Patheon Recent Developments
  67. 8.12 Beximco Pharma
  68. 8.12.1 Beximco Pharma Company Information
  69. 8.12.2 Beximco Pharma Business Overview
  70. 8.12.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio
  72. 8.12.5 Beximco Pharma Recent Developments
  73. 8.13 Albert David
  74. 8.13.1 Albert David Company Information
  75. 8.13.2 Albert David Business Overview
  76. 8.13.3 Albert David Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Albert David Large Volume Parenteral (LVP) Product Portfolio
  78. 8.13.5 Albert David Recent Developments
  79. 8.14 PSI Ltd
  80. 8.14.1 PSI Ltd Company Information
  81. 8.14.2 PSI Ltd Business Overview
  82. 8.14.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 PSI Ltd Large Volume Parenteral (LVP) Product Portfolio
  84. 8.14.5 PSI Ltd Recent Developments
  85. 8.15 Ozon Pharmaceuticals
  86. 8.15.1 Ozon Pharmaceuticals Company Information
  87. 8.15.2 Ozon Pharmaceuticals Business Overview
  88. 8.15.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio
  90. 8.15.5 Ozon Pharmaceuticals Recent Developments
  91. 8.16 BAG Healthcare
  92. 8.16.1 BAG Healthcare Company Information
  93. 8.16.2 BAG Healthcare Business Overview
  94. 8.16.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BAG Healthcare Large Volume Parenteral (LVP) Product Portfolio
  96. 8.16.5 BAG Healthcare Recent Developments
  97. 8.17 BML Parenteral Drugs
  98. 8.17.1 BML Parenteral Drugs Company Information
  99. 8.17.2 BML Parenteral Drugs Business Overview
  100. 8.17.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio
  102. 8.17.5 BML Parenteral Drugs Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Large Volume Parenteral (LVP) Value Chain Analysis
  2. 9.1.1 Large Volume Parenteral (LVP) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Large Volume Parenteral (LVP) Production Mode & Process
  6. 9.2 Large Volume Parenteral (LVP) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Large Volume Parenteral (LVP) Distributors
  9. 9.2.3 Large Volume Parenteral (LVP) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst